The Directorate General of Drug Administration, Ministry of Health & Family Welfare, Government of the People's Republic of Bangladesh, has issued GMP certificate to Incepta. The Drug Administration issues GMP certificates following inspections carried out according to WHO prescribed standards.

Incepta Vaccine Limited, a sister concern of Incepta Pharmaceuticals Ltd recently received GMP certificate, from the Directorate General of Drug Administration.

Incepta Pharmaceuticals Ltd has also been accredited with the European Union GMP certification for its Solid Dosage form plant at Zirabo, Savar, in Bangladesh, a rare and one of the most coveted certifications for regulated markets. The Solid Dosage Plant of the company was inspected by the European authorities and found to be complying with the Manufacturing and Quality Control Standards as per the European Good Manufacturing Practices.

UK MHRA, the regulatory authority of England inspected the Zirabo plant of Incepta Pharmaceuticals Ltd in February 2011. Incepta received the GMP approval certificate for its solid dosage form facility on 20th July 2011 for its own formulated products allowing marketing in UK and other European countries.

Directorate General of Drugs and Pharmaceuticals, Ministry of Health of the Republic of Turkey issued GMP certificates to Incepta Pharmaceuticals Ltd for Tablets, Capsules and Lyophilized Products. Unlike single product GMP certificate which is the normal trend, Incepta received GMP certificate for multiple full lines.

Incepta has received GMP certification from a number of other countries. The relevant departments of the Health Ministry of these countries have issued these GMP certificates

Incepta currently holds the following GMP certifications:

• UK MHRA GMP Certificate
• European Union GMP Certificate
• Turkey GMP Certificate
• Yemen GMP Certificate
• Kenya GMP Certificate
• Democratic Republic of Congo GMP Certificate
• Ethiopia GMP Certificate
• Uganda GMP Certificate
• Sudan GMP Certificate